An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis

Thumbnail Image
Files
An OpenLabelDoseEscalation Study to Assess the Safety and Efficacy of IL22 Agonist F652 in Patients With Alcoholassociated Hepatitis.pdf(84.33 KB)
Date
2020
Authors
Show 10 more
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
URI
https://doi.org/10.1002/hep.31046
 https://repositorio.uc.cl/handle/11534/62411
Collections
Artículos de revistas